Chad Koonce

Seminars

Thursday 2nd October 2025
Translating Research Expertise into Clinical iPSC-Derived Cell Therapeutics
10:00 am
  • The benefit of robust iPSC reprogramming and differentiation methods to achieve efficient translation from research use to clinical therapeutic applications
  • Continuous innovation of an iPSC platform to keep up with the evolving regulatory expectations for iPSC therapeutics
  • Evaluation of iPSC line genomics as a benchmark for quality and regulatory risk